Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 4125731, 9 pages
http://dx.doi.org/10.1155/2016/4125731
Research Article

High Glucose-Induced PC12 Cell Death by Increasing Glutamate Production and Decreasing Methyl Group Metabolism

1School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China
2Lishui Central Hospital, The Fifth Affiliated Hospital, Wenzhou Medical University, Lishui 323000, China

Received 16 March 2016; Revised 18 May 2016; Accepted 23 May 2016

Academic Editor: Paula I. Moreira

Copyright © 2016 Minjiang Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates of the prevalence of diabetes for 2010 and 2030,” Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Hirakawa, H. Arima, S. Zoungas et al., “Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial,” Diabetes Care, vol. 37, no. 8, pp. 2359–2365, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Brock, “Associations between sensorimotor, autonomic and central neuropathies in diabetes mellitus,” Journal of Diabetes & Metabolism, vol. 5, article 390, 2014. View at Publisher · View at Google Scholar
  4. B. C. Callaghan, H. T. Cheng, C. L. Stables, A. L. Smith, and E. L. Feldman, “Diabetic neuropathy: clinical manifestations and current treatments,” The Lancet Neurology, vol. 11, no. 6, pp. 521–534, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Katagi, T. Terashima, J. Okano et al., “Hyperglycemia induces abnormal gene expression in hematopoietic stem cells and their progeny in diabetic neuropathy,” FEBS Letters, vol. 588, no. 6, pp. 1080–1086, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Kumar, T. Raman, M. M. Swain, R. Mishra, and A. Pal, “Hyperglycemia-induced oxidative-nitrosative stress induces inflammation and neurodegeneration via augmented tuberous sclerosis complex-2 (TSC-2) activation in neuronal cells,” Molecular Neurobiology, 2016. View at Publisher · View at Google Scholar
  7. I. G. Obrosova, O. Ilnytska, V. V. Lyzogubov et al., “High-fat diet-induced neuropathy of pre-diabetes and obesity: effects of ‘healthy’ diet and aldose reductase inhibition,” Diabetes, vol. 56, no. 10, pp. 2598–2608, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. J. Thornalley, “Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options,” International Review of Neurobiology, vol. 50, pp. 37–57, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Kamiya, J. Nakamura, Y. Hamada et al., “Polyol pathway and protein kinase C activity of rat Schwannoma cells,” Diabetes/Metabolism Research and Reviews, vol. 19, no. 2, pp. 131–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Geraldes and G. L. King, “Activation of protein kinase C isoforms and its impact on diabetic complications,” Circulation Research, vol. 106, no. 8, pp. 1319–1331, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Nazıroğlu, D. M. Dikici, and Ş. Dursun, “Role of oxidative stress and Ca2+ signaling on molecular pathways of neuropathic pain in diabetes: focus on TRP channels,” Neurochemical Research, vol. 37, no. 10, pp. 2065–2075, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. V. G. Yerra, G. Negi, S. S. Sharma, and A. Kumar, “Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy,” Redox Biology, vol. 1, no. 1, pp. 394–397, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Yadav, A. Shete, P. Yadav, N. Yadav, and S. T. Khan, “Study of nerve conduction velocity in type II diabetes mellitus,” National Journal of Integrated Research in Medicine, vol. 6, no. 4, pp. 36–43, 2015. View at Google Scholar
  14. B. Lacoste, C. H. Comin, A. Ben-Zvi et al., “Sensory-related neural activity regulates the structure of vascular networks in the cerebral cortex,” Neuron, vol. 83, no. 5, pp. 1117–1130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. B.-R. Li, Y.-J. Hsieh, Y.-X. Chen, Y.-T. Chung, C.-Y. Pan, and Y.-T. Chen, “An ultrasensitive nanowire-transistor biosensor for detecting dopamine release from living pc12 cells under hypoxic stimulation,” Journal of the American Chemical Society, vol. 135, no. 43, pp. 16034–16037, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M.-H. Liu, C. Yuan, J. He et al., “Resveratrol protects PC12 cells from high glucose-induced neurotoxicity via PI3K/Akt/FoxO3a pathway,” Cellular and Molecular Neurobiology, vol. 35, no. 4, pp. 513–522, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Najafi, A. M. Sharifi, and A. Hosseini, “Protective effects of alpha lipoic acid on high glucose-induced neurotoxicity in PC12 cells,” Metabolic Brain Disease, vol. 30, no. 3, pp. 731–738, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. V. A. Yürekli, S. Gürler, M. Nazıroğlu, A. C. Uğuz, and H. R. Koyuncuoğlu, “Zonisamide attenuates MPP(+)-induced oxidative toxicity through modulation of Ca2+ signaling and caspase-3 activity in neuronal PC12 cells,” Cellular and Molecular Neurobiology, vol. 33, no. 2, pp. 205–212, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Eslami, A. M. Sharifi, H. Rahimi, and M. Rahati, “Protective effect of telmisartan against oxidative damage induced by high glucose in neuronal PC12 cell,” Neuroscience Letters, vol. 558, pp. 31–36, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Gottschalk, G. Ivanova, D. M. Collins, A. Eustace, R. O'Connor, and D. F. Brougham, “Metabolomic studies of human lung carcinoma cell lines using in vitro  1H NMR of whole cells and cellular extracts,” NMR in Biomedicine, vol. 21, no. 8, pp. 809–819, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Miccheli, R. Ricciolini, E. Piccolella, M. Delfini, and F. Conti, “Modulation of human lymphoblastoid B cell line by phorbol ester and sphingosine. A 31P-NMR study,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1093, no. 1, pp. 29–35, 1991. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Okouchi, N. Okayama, and T. Y. Aw, “Hyperglycemia potentiates carbonyl stress-induced apoptosis in naïve PC-12 cells: relationship to cellular redox and activator protease factor-1 expression,” Current Neurovascular Research, vol. 2, no. 5, pp. 375–386, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. T. Wyss, R. Jolivet, A. Buck, P. J. Magistretti, and B. Weber, “In vivo evidence for lactate as a neuronal energy source,” The Journal of Neuroscience, vol. 31, no. 20, pp. 7477–7485, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Avogaro, R. Nosadini, A. Doria et al., “Substrate availability other than glucose in the brain during euglycemia and insulin-induced hypoglycemia in dogs,” Metabolism, vol. 39, no. 1, pp. 46–50, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Zheng, Y. Zheng, D. Wang et al., “Analysis of neuron-astrocyte metabolic cooperation in the brain of db/db mice with cognitive decline using 13C NMR spectroscopy,” Journal of Cerebral Blood Flow & Metabolism, 2016. View at Publisher · View at Google Scholar
  26. E. Strumia, F. Pelliccia, and G. D'Ambrosio, “Creatine phosphate: pharmacological and clinical perspectives,” Advances in Therapy, vol. 29, no. 2, pp. 99–123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. E. Mccormack, O. Shaham, M. A. Mccarthy et al., “Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents,” Pediatric Obesity, vol. 8, no. 1, pp. 52–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. H. S. Waagepetersen, U. Sonnewald, O. M. Larsson, and A. Schousboe, “A possible role of alanine for ammonia transfer between astrocytes and glutamatergic neurons,” Journal of Neurochemistry, vol. 75, no. 2, pp. 471–479, 2000. View at Google Scholar · View at Scopus
  29. M. J. Niciu, B. Kelmendi, and G. Sanacora, “Overview of glutamatergic neurotransmission in the nervous system,” Pharmacology Biochemistry and Behavior, vol. 100, no. 4, pp. 656–664, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. L. K. Bak, A. Schousboe, and H. S. Waagepetersen, “The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer,” Journal of Neurochemistry, vol. 98, no. 3, pp. 641–653, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Zhang and X. F. Gu, “A study of gene expression profiles of cultured embryonic rat neurons induced by phenylalanine,” Metabolic Brain Disease, vol. 20, no. 1, pp. 61–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Zhang, X. Gu, and X. Yuan, “Phenylalanine activates the mitochondria-mediated apoptosis through the RhoA/Rho-associated kinase pathway in cortical neurons,” European Journal of Neuroscience, vol. 25, no. 5, pp. 1341–1348, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Hohmann, “An integrated view on a eukaryotic osmoregulation system,” Current Genetics, vol. 61, no. 3, pp. 373–382, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Oenarto, B. Görg, M. Moos, H.-J. Bidmon, and D. Häussinger, “Expression of organic osmolyte transporters in cultured rat astrocytes and rat and human cerebral cortex,” Archives of Biochemistry and Biophysics, vol. 560, pp. 59–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M. van der Graaf, S. W. J. Janssen, J. J. A. van Asten et al., “Metabolic profile of the hippocampus of Zucker Diabetic Fatty rats assessed by in vivo 1H magnetic resonance spectroscopy,” NMR in Biomedicine, vol. 17, no. 6, pp. 405–410, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Kantarci, “1H magnetic resonance spectroscopy in dementia,” British Journal of Radiology, vol. 80, no. 2, pp. S146–S152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Horská, L. Farage, G. Bibat et al., “Brain metabolism in Rett syndrome: age, clinical, and genotype correlations,” Annals of Neurology, vol. 65, no. 1, pp. 90–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Michel, Z. Yuan, S. Ramsubir, and M. Bakovic, “Choline transport for phospholipid synthesis,” Experimental Biology and Medicine, vol. 231, no. 5, pp. 490–504, 2006. View at Google Scholar · View at Scopus
  39. K. T. Williams and K. L. Schalinske, “New insights into the regulation of methyl group and homocysteine metabolism,” The Journal of Nutrition, vol. 137, no. 2, pp. 311–314, 2007. View at Google Scholar · View at Scopus
  40. E. Wainfan and L. A. Poirier, “Methyl groups in carcinogenesis: effects on DNA methylation and gene expression,” Cancer Research, vol. 52, no. 7, pp. 2071s–2077s, 1992. View at Google Scholar · View at Scopus
  41. R. Surtees, K. Hyland, and I. Smith, “Central-nervous-system methyl-group metabolism in children with neurological complications of HIV infection,” The Lancet, vol. 335, no. 8690, pp. 619–621, 1990. View at Publisher · View at Google Scholar · View at Scopus
  42. S. E. Washburn, M. A. Caudil, O. Malysheva et al., “Formate metabolism in fetal and neonatal sheep,” American Journal of Physiology-Endocrinology and Metabolism, vol. 308, no. 10, pp. E921–E927, 2015. View at Publisher · View at Google Scholar · View at Scopus